Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1680 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Trichorhinophalangeal I Syndrome, Type / III | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| TRPS1 | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
TRPS1 related disorders - Trichorhinophalangeal syndrome type I (TRPS I; MIM 190350) and type III (TRPS III; MIM 190351) are allelic autosomal dominant disorders characterized by craniofacial and skeletal abnormalities. TRPS is characterized by slow growing, sparse scalp hair, laterally sparse eyebrows, a pear shaped nose with a bulbous tip, a long flat philtrum, a thin upper vermillion border, protruding ears, and postnatal, progressive growth retardation. Skeletal abnormalities include cone shaped epiphyses of the phalanges and other bones, shortening of the phalanges and metacarpals, hip malformations and short stature. The skeletal age lags behind the chronological age until puberty. Patients with TRPS III are more severely affected than those with TRPS I and are typically shorter and have more severe brachydactyly involving all tubular bones of the hands. They may also have additional skeletal abnormalities. TRPS I and TRPS III are caused by mutations in the zinc-finger transcription factor gene, TRPS1. TRPS1 haploinsufficiency is considered the major cause of TRPS I. TRPS III is typically caused by mutations resulting in substitutions in a specific DNA binding domain. It is proposed that these mutations exert a dominant negative effect. Trichorhinophalangeal syndrome, type II (TRPS II) shares many clinical features with TRPS I and TRPS III; however, patients with TRPS II have multiple cartilaginous exostoses, mental retardation, and some may have microcephaly. TRPS II is a contiguous gene syndrome caused by the deletion of the TRPS1 and EXT1 genes. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| TRPS1 | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 190350, 190351 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Craniosynostosis and Craniofacial Disorders, Hair and Nail disorders, Skeletal Disorders, Skin | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.